|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
SCIDIR_ocn868955791 |
003 |
OCoLC |
005 |
20231117044948.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
131014t20142014ne a ob 001 0 eng d |
040 |
|
|
|a E7B
|b eng
|e rda
|e pn
|c E7B
|d OCLCO
|d N$T
|d OPELS
|d YDXCP
|d MYG
|d OCLCF
|d NKT
|d OCLCQ
|d U3W
|d D6H
|d AU@
|d S2H
|d OCLCO
|d TUHNV
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|
020 |
|
|
|a 9780123972286
|q (electronic bk.)
|
020 |
|
|
|a 0123972280
|q (electronic bk.)
|
020 |
|
|
|a 9780123965219
|q (electronic bk.)
|
020 |
|
|
|a 0123965217
|q (electronic bk.)
|
020 |
|
|
|z 9780123965219
|
035 |
|
|
|a (OCoLC)868955791
|
050 |
|
4 |
|a RS431.A64
|b N45 2014eb
|
060 |
|
4 |
|a QV 269
|b N453 2014eb
|
072 |
|
7 |
|a TEC
|x 040000
|2 bisacsh
|
082 |
0 |
4 |
|a 615.7/98
|2 23
|
082 |
0 |
4 |
|a 673
|
100 |
1 |
|
|a Neidle, Stephen,
|e editor.
|
245 |
1 |
0 |
|a Cancer Drug Design and Discovery /
|c Stephen Neidle, School of Pharmacy, University College London, UK.
|
250 |
|
|
|a Second edition.
|
264 |
|
1 |
|a Amsterdam [Netherlands] :
|b Elsevier,
|c [2014]
|
264 |
|
4 |
|c �2014
|
300 |
|
|
|a 1 online resource (673 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Part 1. Basic principles and methodology -- part II. Drugs in the laboratory and clinic -- part III. The reality of cancerdrugs in the clinic.
|
588 |
0 |
|
|a Online resource; title from PDF title page (ebrary, viewed October 28, 2013).
|
520 |
|
|
|a Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under develo.
|
650 |
|
0 |
|a Antineoplastic agents
|x Design.
|
650 |
|
0 |
|a Cancer
|x Chemotherapy.
|
650 |
|
0 |
|a Antineoplastic agents.
|
650 |
|
0 |
|a Antimitotic agents.
|
650 |
|
0 |
|a Drugs
|x Design.
|
650 |
1 |
2 |
|a Antineoplastic Agents
|0 (DNLM)D000970
|
650 |
|
2 |
|a Antimitotic Agents
|0 (DNLM)D050256
|
650 |
2 |
2 |
|a Drug Design
|0 (DNLM)D015195
|
650 |
2 |
2 |
|a Neoplasms
|x drug therapy
|0 (DNLM)D009369Q000188
|
650 |
|
6 |
|a Cancer
|x Chimioth�erapie.
|0 (CaQQLa)201-0004691
|
650 |
|
6 |
|a Anticanc�ereux.
|0 (CaQQLa)201-0004692
|
650 |
|
6 |
|a M�edicaments
|x Conception.
|0 (CaQQLa)201-0203461
|
650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Technical & Manufacturing Industries & Trades.
|2 bisacsh
|
650 |
|
7 |
|a Drugs
|x Design
|2 fast
|0 (OCoLC)fst00898790
|
650 |
|
7 |
|a Antineoplastic agents
|2 fast
|0 (OCoLC)fst00810595
|
650 |
|
7 |
|a Antimitotic agents
|2 fast
|0 (OCoLC)fst00810570
|
650 |
|
7 |
|a Antineoplastic agents
|x Design
|2 fast
|0 (OCoLC)fst00810598
|
650 |
|
7 |
|a Cancer
|x Chemotherapy
|2 fast
|0 (OCoLC)fst00845327
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780123965219
|z Texto completo
|